| __timestamp | Catalent, Inc. | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 334800000 | 91733000 |
| Thursday, January 1, 2015 | 337300000 | 87644000 |
| Friday, January 1, 2016 | 358100000 | 92365000 |
| Sunday, January 1, 2017 | 402600000 | 85656000 |
| Monday, January 1, 2018 | 462600000 | 88196000 |
| Tuesday, January 1, 2019 | 512000000 | 89971000 |
| Wednesday, January 1, 2020 | 577900000 | 93413000 |
| Friday, January 1, 2021 | 687000000 | 91355000 |
| Saturday, January 1, 2022 | 844000000 | 113676000 |
| Sunday, January 1, 2023 | 831000000 | 198366000 |
| Monday, January 1, 2024 | 935000000 | 218935000 |
In pursuit of knowledge
In the competitive landscape of the pharmaceutical industry, effective cost management is crucial. Catalent, Inc. and Taro Pharmaceutical Industries Ltd. offer a fascinating study in contrasts when it comes to Selling, General, and Administrative (SG&A) expenses. Over the past decade, Catalent has seen a steady increase in SG&A expenses, rising by approximately 180% from 2014 to 2024. This growth reflects their aggressive expansion and investment in operational capabilities. In contrast, Taro Pharmaceutical's SG&A expenses have remained relatively stable, with a notable spike in 2023, reaching nearly double their 2014 levels. This sudden increase could indicate strategic shifts or unexpected operational costs. Understanding these trends provides valuable insights into each company's strategic priorities and operational efficiencies. As the industry evolves, monitoring these expenses will be key to assessing financial health and competitive positioning.
Bristol-Myers Squibb Company or Catalent, Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Bristol-Myers Squibb Company or Taro Pharmaceutical Industries Ltd.
Selling, General, and Administrative Costs: Catalent, Inc. vs Cytokinetics, Incorporated
Catalent, Inc. or Ionis Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Catalent, Inc. or Perrigo Company plc
Who Optimizes SG&A Costs Better? Catalent, Inc. or Dynavax Technologies Corporation
Who Optimizes SG&A Costs Better? Lantheus Holdings, Inc. or Taro Pharmaceutical Industries Ltd.
Selling, General, and Administrative Costs: Ultragenyx Pharmaceutical Inc. vs Taro Pharmaceutical Industries Ltd.
Breaking Down SG&A Expenses: Rhythm Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
ACADIA Pharmaceuticals Inc. vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Supernus Pharmaceuticals, Inc. or Taro Pharmaceutical Industries Ltd.
Who Optimizes SG&A Costs Better? Amphastar Pharmaceuticals, Inc. or Taro Pharmaceutical Industries Ltd.